Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway—A translational study
- 5 August 2023
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 208, 103-111
Abstract
No abstract availableKeywords
Funding Information
- National Health Research Institutes (NHRI-EX106-10618SC)
- Chi Mei Medical Center
- National Science and Technology Council
- Ministry of Science and Technology, Taiwan (108-2628-B-384, MOST105-2628-B-384 -001 -MY3)
This publication has 40 references indexed in Scilit:
- Even free radicals should follow some rules: A Guide to free radical research terminology and methodologyFree Radical Biology and Medicine, 2015
- What is the best way to measure renal fibrosis?: A pathologist’s perspectiveKidney International Supplements, 2014
- Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trialAnnals of Oncology, 2013
- Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Lymphoma Nude Mice by Heme Oxygenase-1 InductionCardiovascular Toxicology, 2012
- Metabolic caging for animal researchLab Animal, 2012
- Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitationsFree Radical Biology and Medicine, 2012
- Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stressMolecular and Cellular Biochemistry, 2011
- Upregulation of renal eNOS by high-sodium diet facilitates hypertension in doxorubicin-treated rats through enhanced oxidative stressToxicology, 2006
- A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosisAmerican Journal of Physiology-Cell Physiology, 2003
- Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody indb/dbdiabetic miceProceedings of the National Academy of Sciences, 2000